Kaj Blennow
Physiology · 2001–2024
A researcher in the Science corpus: 44 papers; trusts 13 researchers and is trusted by 12 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 357 citations into it; #167 of 2,276 by trust here, #36 by citations
- Psychiatry and Mental health — 264 citations into it; #94 of 1,338 by trust here, #10 by citations
- Neurology — 167 citations into it; #768 of 1,455 by trust here, #98 by citations
- Molecular Biology — 152 citations into it
- Pharmacology — 44 citations into it; #295 of 1,112 by trust here, #193 by citations
- Public Health, Environmental and Occupational Health — 22 citations into it
- Computational Theory and Mathematics — 18 citations into it
Whom Kaj Blennow trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- D. Selkoe
- Oskar Hansson
- Bruno Dubois
- Harald Hampel
- Ronald C. Petersen
- Henrik Zetterberg
- Ann C. McKee
- Steven DeKosky
- B. Omalu
- N. Andreasen
Who trusts Kaj Blennow overall
- Michael G. Erkkinen
- Henrik Zetterberg
- Oskar Hansson
- Clifford R. Jack Jr.
- Mee‐Ohk Kim
- Shaker El-Sappagh
- Bruno Dubois
- Harald Hampel
- Michael D. Geschwind
- I. Hamley
Papers from Kaj Blennow's perspective
Ordered by how strongly the researchers Kaj Blennow trusts endorse each paper. Same corpus, a different order for every researcher.
- Current concepts in mild cognitive impairment. (Archives of Neurology)
- Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade (Lancet Neurology)
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory (Journal of Neuroscience)
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (Nature reviews. Drug discovery)
- Mild cognitive impairment as a diagnostic entity (Journal of Internal Medicine)
- Primary age-related tauopathy (PART): a common pathology associated with human aging (Acta Neuropathologica)
- The pathological process underlying Alzheimer’s disease in individuals under thirty (Acta Neuropathologica)
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment (Journal of Internal Medicine)
- Biomarker Modeling of Alzheimer's Disease (Neuron)
- Research criteria for subcortical vascular dementia in clinical trials. (Journal of neural transmission. Supplementum)
Their papers
- Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins (2007) — 1,096 citations
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (2010) — 659 citations
- Cerebrospinal Fluid Biomarker Signature in Alzheimer’s Disease Neuroimaging Initiative Subjects (2009) — 2,163 citations
- Gut microbiome alterations in Alzheimer’s disease (2017) — 1,842 citations
- Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers (2005) — 166 citations
- Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology (2024) — 702 citations
- A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease (2021) — 813 citations
- Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group (2021) — 763 citations
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration (2020) — 613 citations
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. (2020) — 1,081 citations
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (2020) — 1,061 citations
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. (2020) — 1,288 citations
- Neurofilament light chain as a biomarker in neurological disorders (2019) — 1,161 citations
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. (2019) — 678 citations
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. (2019) — 650 citations
- CSF biomarkers of Alzheimer’s disease concord with amyloid-β PETand predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts (2018) — 715 citations
- Biomarkers for Alzheimer's disease: current status and prospects for the future (2018) — 827 citations
- Neurofilaments as biomarkers in neurological disorders (2018) — 1,788 citations
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity (2017) — 834 citations
- Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis (2017) — 1,094 citations